Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17718 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Ryo Amagai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Melanoma, Proto-Oncogene Proteins B-raf, Skin Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
The combination of BRAF and MEK kinase inhibitors is a well‐established treatment for BRAF V600‐mutated advanced melanoma. However, the efficacy of these therapies against less common BRAF mutations, such as BRAF L597, remains unclear. We report two cases of advanced melanoma harboring the BRAF L597 mutation. In the first case, a 77‐year‐old man with metastatic melanoma achieved complete remission following combination therapy with nivolumab and ipilimumab. In the second case, a 50‐year‐old woman with metastatic melanoma exhibited resistance to multiple systemic therapies, including nivolumab, ipilimumab, and targeted therapy with encorafenib and binimetinib. These cases highlight the variable therapeutic responses in melanoma with the BRAF L597 mutation, suggesting that immune checkpoint inhibitors may be a viable first‐line treatment, particularly for patients with a high tumor mutational burden. Further studies are needed to establish optimal treatment strategies for this rare mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Ryo Amagai, Taku Fujimura, Yumi Kambayashi, Manami Takahashi-Watanabe, Emi Yamazaki, Yusuke Muto, Yoshihide Asano
Zitieren
APA
Amagai, R., Fujimura, T., Kambayashi, Y., Takahashi-Watanabe, M., Yamazaki, E., Tamabuchi, E., Oka, K., Muto, Y., Hashimoto, A., & Asano, Y. (2025). Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17718
Vancouver
Amagai R, Fujimura T, Kambayashi Y, Takahashi-Watanabe M, Yamazaki E, Tamabuchi E, et al. Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17718
BibTeX
@article{Amagai2025,
author = {Amagai, Ryo and Fujimura, Taku and Kambayashi, Yumi and Takahashi-Watanabe, Manami and Yamazaki, Emi and Tamabuchi, Erika and Oka, Kenta and Muto, Yusuke and Hashimoto, Akira and Asano, Yoshihide},
title = {Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17718}
}
EUVIMED